These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 16093528)

  • 1. Partly cloudy.
    Davenport RJ
    Sci Aging Knowledge Environ; 2005 Aug; 2005(32):nf63. PubMed ID: 16093528
    [No Abstract]   [Full Text] [Related]  

  • 2. [Progress in Alzheimer research].
    Tabira T
    Nihon Ronen Igakkai Zasshi; 2001 Nov; 38(6):723-34. PubMed ID: 11774708
    [No Abstract]   [Full Text] [Related]  

  • 3. Association of apolipoprotein E polymorphism with age-related macular degeneration and Alzheimer's disease in south-western Hungary.
    Kovács KA; Pámer Z; Kovács A; Fekete S; Miseta A; Kovács B; Kovács GL
    Ideggyogy Sz; 2007 Mar; 60(3-4):169-72. PubMed ID: 17451062
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nature throws curveballs: APOE and nonlinear decline in Alzheimer disease.
    Camicioli R; Kryscio R
    Neurology; 2005 Dec; 65(12):1855-6. PubMed ID: 16380605
    [No Abstract]   [Full Text] [Related]  

  • 5. A deficit in astroglial organization causes the impaired reactive sprouting in human apolipoprotein E4 targeted replacement mice.
    Blain JF; Sullivan PM; Poirier J
    Neurobiol Dis; 2006 Mar; 21(3):505-14. PubMed ID: 16171999
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Age-related macular degeneration and functional promoter and coding variants of the apolipoprotein E gene.
    Fritsche LG; Freitag-Wolf S; Bettecken T; Meitinger T; Keilhauer CN; Krawczak M; Weber BH
    Hum Mutat; 2009 Jul; 30(7):1048-53. PubMed ID: 19384966
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of APOE genotype on clinical phenotype in Alzheimer disease.
    Borroni B; Di Luca M; Padovani A
    Neurology; 2007 Feb; 68(8):624; author reply 624. PubMed ID: 17310043
    [No Abstract]   [Full Text] [Related]  

  • 8. Apolipoprotein E and Alzheimer disease.
    Huang Y
    Neurology; 2006 Jan; 66(2 Suppl 1):S79-85. PubMed ID: 16432152
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular and cellular mechanisms of apolipoprotein E4 neurotoxicity and potential therapeutic strategies.
    Huang Y
    Curr Opin Drug Discov Devel; 2006 Sep; 9(5):627-41. PubMed ID: 17002223
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular genetics of AMD and current animal models.
    Edwards AO; Malek G
    Angiogenesis; 2007; 10(2):119-32. PubMed ID: 17372852
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Apolipoprotein E genotype and risk for development of cataract and age-related macular degeneration.
    Utheim ØA; Ritland JS; Utheim TP; Espeseth T; Lydersen S; Rootwelt H; Semb SO; Elsås T
    Acta Ophthalmol; 2008 Jun; 86(4):401-3. PubMed ID: 18498549
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 5-Lipoxygenase (ALOX5) and FLAP (ALOX5AP) gene polymorphisms as factors in vascular pathology and Alzheimer's disease.
    Manev H; Manev R
    Med Hypotheses; 2006; 66(3):501-3. PubMed ID: 16278051
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ApoE genotype and family history in patients with dementia and cognitively intact spousal controls.
    Zintl M; Schmitz G; Hajak G; Klünemann HH
    Am J Alzheimers Dis Other Demen; 2009; 24(4):349-52. PubMed ID: 19372276
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Age-related macular degeneration: its association with the epsilon4 allele of the apolipoprotein E gene].
    Asensio-Sánchez VM; Rodríguez-Martín T; Gala-Molina I; Rodríguez-Fernández I
    Arch Soc Esp Oftalmol; 2006 Jan; 81(1):9-12. PubMed ID: 16450255
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Apolipoprotein E gene and macular degeneration.
    Waugh WH
    Ophthalmology; 2006 Oct; 113(10):1888-9; author reply 1889. PubMed ID: 17011970
    [No Abstract]   [Full Text] [Related]  

  • 16. [Molecular genetics of Alzheimer's disease].
    Akinori M; Ryozo K
    Tanpakushitsu Kakusan Koso; 2005 Dec; 50(16 Suppl):2122-7. PubMed ID: 16411440
    [No Abstract]   [Full Text] [Related]  

  • 17. Apolipoprotein E represents a potent gene-based therapeutic target for the treatment of sporadic Alzheimer's disease.
    Poirier J
    Alzheimers Dement; 2008 Jan; 4(1 Suppl 1):S91-7. PubMed ID: 18632009
    [No Abstract]   [Full Text] [Related]  

  • 18. Apolipoprotein E genotype and alpha-tocopherol modulate amyloid precursor protein metabolism and cell cycle regulation.
    Huebbe P; Schaffer S; Jofre-Monseny L; Boesch-Saadatmandi C; Minihane AM; Müller WE; Eckert GP; Rimbach G
    Mol Nutr Food Res; 2007 Dec; 51(12):1510-7. PubMed ID: 18030662
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interleukin-6 promoter polymorphism and late-onset Alzheimer's disease in the Finnish population.
    Koivisto AM; Helisalmi S; Pihlajamäki J; Moilanen L; Kuusisto J; Laakso M; Hiltunen M; Keijo K; Hänninen T; Helkala EL; Kervinen K; Kesäniemi YA; Soininen H
    J Neurogenet; 2005; 19(3-4):155-61. PubMed ID: 16540406
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic association of ubiquilin with Alzheimer's disease and related quantitative measures.
    Kamboh MI; Minster RL; Feingold E; DeKosky ST
    Mol Psychiatry; 2006 Mar; 11(3):273-9. PubMed ID: 16302009
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.